Jon P Stonehouse Insider Trading $BCRX BIOCRYST PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jon P Stonehouse.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jon P Stonehouse. Jon P Stonehouse is CEO in BIOCRYST PHARMACEUTICALS INC ($BCRX) and President & CEO in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in BELLICUM PHARMACEUTICALS, INC ($BLCM).
Jon P Stonehouse in BIOCRYST PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jon P Stonehouse: President & CEO, CEO
Holdings: 918,364 shares
Current Value: $5,207,124
Latest Transaction: Dec 17 2020
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jon P Stonehouse in BIOCRYST PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17 2020 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 8.31 | 870,000 | 7,229,700 | 870,000 | |
| Dec 17 2020 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | M | 4.15 | 134,278 | 557,254 | 1 | |
| Dec 17 2020 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Sell | S | 8.32 | 134,278 | 1,117,193 | 784,086 | 918.4 K to 784.1 K (-14.62 %) |
| Dec 17 2020 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | M | 4.15 | 134,278 | 557,254 | 918,364 | 784.1 K to 918.4 K (+17.13 %) |
| Dec 07 2020 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 3.23 | 157,250 | 507,918 | 157,250 | |
| Dec 07 2020 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 5.45 | 25,000 | 136,250 | 25,000 | |
| May 15 2020 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 3.23 | 157,250 | 507,918 | 157,250 | |
| Feb 25 2020 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 12.16 | 27,140 | 330,022 | 27,140 | |
| Feb 19 2020 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 12.16 | 47,495 | 577,539 | 47,495 | |
| Dec 19 2019 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 3.23 | 314,500 | 1,015,835 | 314,500 | |
| Nov 18 2019 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 1.45 | 50,000 | 72,500 | 778,086 | 728.1 K to 778.1 K (+6.87 %) |
| Jan 03 2019 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Payment of Exercise | F | 8.07 | 3,568 | 28,794 | 724,106 | 727.7 K to 724.1 K (-0.49 %) |
| Dec 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 7.06 | 675,000 | 4,765,500 | 675,000 | |
| May 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | M | 1.42 | 70,427 | 100,006 | 297,573 | |
| May 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | M | 1.42 | 70,427 | 100,006 | 725,519 | 655.1 K to 725.5 K (+10.75 %) |
| Mar 02 2018 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | M | 3.26 | 56,949 | 185,654 | 0 | |
| Mar 02 2018 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Payment of Exercise | F | 4.97 | 43,224 | 214,823 | 655,092 | 698.3 K to 655.1 K (-6.19 %) |
| Mar 02 2018 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | M | 3.26 | 56,949 | 185,654 | 698,316 | 641.4 K to 698.3 K (+8.88 %) |
| Jan 23 2018 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Payment of Exercise | F | 5.59 | 9,584 | 53,575 | 638,367 | 648 K to 638.4 K (-1.48 %) |
| Jan 03 2018 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Payment of Exercise | F | 4.91 | 2,716 | 13,336 | 647,951 | 650.7 K to 648 K (-0.42 %) |
| Dec 22 2017 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 5.04 | 300,000 | 1,512,000 | 300,000 | |
| Sep 05 2017 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 12.16 | 40,710 | 495,034 | 40,710 | |
| Mar 01 2017 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 5.51 | 500,000 | 2,755,000 | 500,000 | |
| Jan 24 2017 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Payment of Exercise | F | 5.95 | 10,572 | 62,903 | 645,418 | 656 K to 645.4 K (-1.61 %) |
| Jan 03 2017 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Payment of Exercise | F | 6.33 | 8,595 | 54,406 | 655,990 | 664.6 K to 656 K (-1.29 %) |
| May 25 2016 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 3.22 | 337,050 | 1,085,301 | 337,050 | |
| Mar 03 2016 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Payment of Exercise | F | 2.13 | 2,761 | 5,881 | 664,585 | 667.3 K to 664.6 K (-0.41 %) |
| Jan 22 2016 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Payment of Exercise | F | 7.55 | 10,624 | 80,211 | 665,702 | 676.3 K to 665.7 K (-1.57 %) |
| Jan 21 2016 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | M | 4.15 | 24,096 | 99,998 | 134,279 | |
| Jan 21 2016 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | M | 4.15 | 24,096 | 99,998 | 676,326 | 652.2 K to 676.3 K (+3.69 %) |
| Jan 05 2016 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Payment of Exercise | F | 10.32 | 8,091 | 83,499 | 652,230 | 660.3 K to 652.2 K (-1.23 %) |
| Dec 31 2015 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 10.82 | 162,950 | 1,763,119 | 162,950 | |
| Jul 17 2015 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | M | 11.81 | 33,868 | 399,981 | 416,132 | |
| Jul 17 2015 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Payment of Exercise | F | 15.67 | 25,526 | 399,992 | 659,211 | 684.7 K to 659.2 K (-3.73 %) |
| Jul 17 2015 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | M | 11.81 | 33,868 | 399,981 | 684,737 | 650.9 K to 684.7 K (+5.20 %) |
| Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | M | 1.20 | 20,000 | 24,000 | 80,000 | |
| Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Sell | S | 15.02 | 20,000 | 300,400 | 650,869 | 670.9 K to 650.9 K (-2.98 %) |
| Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | M | 1.20 | 20,000 | 24,000 | 670,869 | 650.9 K to 670.9 K (+3.07 %) |
| Jun 16 2015 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 5.45 | 25,000 | 136,250 | 25,000 | |
| Mar 03 2015 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Payment of Exercise | F | 10.20 | 5,118 | 52,204 | 650,869 | 656 K to 650.9 K (-0.78 %) |
| Mar 18 2011 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 3.40 | 10,000 | 33,988 | 194,180 | 184.2 K to 194.2 K (+5.43 %) |
| Mar 03 2011 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 4.15 | 168,000 | 697,200 | 168,000 | |
| Mar 03 2011 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Grant | A | 0.00 | 28,500 | 0 | 184,180 | 155.7 K to 184.2 K (+18.31 %) |
| Mar 04 2010 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 6.68 | 143,800 | 960,584 | 143,800 | |
| Mar 04 2009 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 1.20 | 279,600 | 335,520 | 279,600 | |
| Feb 03 2009 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 1.62 | 3,000 | 4,845 | 103,603 | 100.6 K to 103.6 K (+2.98 %) |
| Dec 02 2008 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 1.48 | 55,000 | 81,450 | 155,603 | 100.6 K to 155.6 K (+54.67 %) |
| Nov 03 2008 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 1.75 | 22,900 | 40,075 | 100,603 | 77.7 K to 100.6 K (+29.47 %) |
| Nov 03 2008 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 1.74 | 2,100 | 3,654 | 77,703 | 75.6 K to 77.7 K (+2.78 %) |
| Aug 13 2008 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 3.10 | 2,300 | 7,124 | 75,603 | 73.3 K to 75.6 K (+3.14 %) |
| Aug 13 2008 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 2.95 | 7,700 | 22,736 | 73,303 | 65.6 K to 73.3 K (+11.74 %) |
| Aug 04 2008 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 2.82 | 240 | 677 | 65,603 | 65.4 K to 65.6 K (+0.37 %) |
| Mar 18 2008 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 3.26 | 60,750 | 198,045 | 60,750 | |
| Feb 04 2008 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 3.50 | 3,000 | 10,506 | 65,363 | 62.4 K to 65.4 K (+4.81 %) |
| Aug 14 2007 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 9.86 | 2,650 | 26,129 | 62,363 | 59.7 K to 62.4 K (+4.44 %) |
| Aug 14 2007 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 9.95 | 3,700 | 36,815 | 59,713 | 56 K to 59.7 K (+6.61 %) |
| Aug 14 2007 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 9.94 | 1,500 | 14,910 | 56,013 | 54.5 K to 56 K (+2.75 %) |
| Aug 14 2007 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 9.87 | 356 | 3,514 | 54,513 | 54.2 K to 54.5 K (+0.66 %) |
| Aug 14 2007 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 9.85 | 144 | 1,418 | 54,157 | 54 K to 54.2 K (+0.27 %) |
| Aug 14 2007 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 9.84 | 50 | 492 | 54,013 | 54 K to 54 K (+0.09 %) |
| Aug 14 2007 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 9.81 | 1,400 | 13,734 | 53,963 | 52.6 K to 54 K (+2.66 %) |
| Aug 14 2007 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | P | 9.80 | 100 | 980 | 52,563 | 52.5 K to 52.6 K (+0.19 %) |
| Aug 02 2007 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | CEO | Buy | P | 7.06 | 2,463 | 17,376 | 52,463 | 50 K to 52.5 K (+4.93 %) |
| Jan 09 2007 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | CEO | Option Exercise | A | 11.81 | 450,000 | 5,314,500 | 450,000 | |
| Jan 09 2007 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | CEO | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Page: 1